In our cell experiments, TNF-α and IL-6 were highly expressed in PRAD cell lines and positively regulated by ARRB2, suggesting that ARRB2 could affect PRAD tumor progression by regulating the expression of IFs. Here, ARRB2 is linked to prostate adenocarcinoma.